Drugs / Ringer lactate
Ringer lactate
Trials 12 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02709044 | Feb 2016 → Mar 2018 | acute pancreatitis | University Hospital Rijeka | Unknown | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT03654001 | May 2019 → Oct 2024 | infectious disease with sepsis | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Completed | No outcome recorded |
| Phase 3 | NCT03118362 | Aug 2017 → Sep 2018 | — | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT00318942 | Feb 2003 → Aug 2012 | — | University of Versailles | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT06541535 | Nov 2025 → Dec 2027 expected | diabetic ketoacidosis | Centre Hospitalier Universitaire de Nice | Recruiting | No outcome recorded |
| Phase 4 | NCT05777135 | Apr 2023 → Mar 2024 | — | National Medical College Birgunj | Unknown | No outcome recorded |
| Phase 4 | NCT03799250 | Jun 2019 → Dec 2020 | — | Rabin Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT03115060 | Apr 2015 → Apr 2018 | disorder of acid-base balance | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| Phase 4 | NCT00797589 | Jan 2009 → Sep 2012 | heart valve disorder | University of Helsinki | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT05921695 | May 2023 → Jun 2026 | — | Second Affiliated Hospital, School of Medicine, Zhejiang University | Terminated | No outcome recorded |
| — | NCT02936167 | Sep 2016 → Feb 2017 | — | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| — | NCT01729364 | Apr 2008 → Dec 2014 | impaired renal function disease | Sahlgrenska University Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 19 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03697330 Comparator | Jan 2018 → Jun 2019 | — | Assiut University | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT06847594 Comparator | Feb → Sep 2024 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT03043131 Comparator | Feb → Sep 2017 | — | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| Phase 3 | NCT02782520 Comparator | Aug 2016 → Oct 2017 | — | University Hospital, Grenoble | Completed | No outcome recorded |
| Phase 3 | NCT05223361 Comparator | Apr 2016 → Apr 2021 | heart valve disorder | Rajaie Cardiovascular Medical and Research Center | Completed | No outcome recorded |
| Phase 46 trials | ||||||
| Phase 4 | NCT07035509 Comparator | Jul 2025 → Jul 2026 overdue | infectious disease with sepsis | Fundación Cardioinfantil Instituto de Cardiología | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05808972 Comparator | Nov 2022 → Dec 2023 | diabetic ketoacidosis | Tunis University | Completed | No outcome recorded |
| Phase 4 | NCT03771170 Comparator | Jan 2018 → Dec 2019 | peritonitis, poisoning | Yuria-Pharm | Completed | No outcome recorded |
| Phase 4 | NCT03824457 Comparator | Jan 2018 → Feb 2020 | pneumonia | Yuria-Pharm | Completed | No outcome recorded |
| Phase 4 | NCT00860704 Comparator | Nov 2007 → Dec 2012 | — | Medical University of Vienna | Completed | No outcome recorded |
| Phase 4 | NCT01174719 Comparator | Mar 2006 → Feb 2010 | coronary artery disorder, heart valve disorder | Medical University of Vienna | Completed | No outcome recorded |
| Phase not applicable8 trials | ||||||
| — | NCT06654687 Comparator | Oct 2024 → Feb 2025 | pregnancy disorder | Sameh Fathy | Completed | No outcome recorded |
| — | NCT05318066 Comparator | Jul 2022 → Nov 2023 overdue | — | Tata Memorial Centre | Active not recruiting | No outcome recorded |
| — | NCT06835023 Comparator | Jan 2022 → May 2025 overdue | acute pancreatitis | Satu Mare County Emergency Hospital | Recruiting | No outcome recorded |
| — | NCT02782819 Comparator | Sep 2014 → Aug 2018 | hypotensive disorder | Mahidol University | Unknown | No outcome recorded |
| — | NCT02071524 Comparator | Sep 2013 → Mar 2017 | — | Università degli Studi di Ferrara | Unknown | No outcome recorded |
| — | NCT01344499 Comparator | Aug 2009 → Sep 2011 | — | University Hospital, Gasthuisberg | Completed | No outcome recorded |
| — | NCT00854386 Comparator | May 2009 → May 2011 | acute lung injury, acute respiratory distress syndrome, infectious disease with sepsis | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT01972828 Background | Jul 2007 → Aug 2013 | infectious disease with sepsis | Hospices Civils de Lyon | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 33 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ringer Lactate | “The aim of the study is to compare three different regimens for volume replacement during cardiac surgery, e.g. Albumin 5%, Hydroxyethylstarch 130/0.4 (HES) and Ringer-Lactate (RL).” NCT01174719 ↗30“Isotonic or hypertonic saline or Ringer Lactate or any other crystalloids, at the necessary dose to restore hemodynamic for all ICU stay” NCT00318942 ↗ “Patients in the restrictive group (RG) will receive 2 ml/kg•hr of Ringer Lactate (RL) solution throughout the intraoperative period” NCT00854386 ↗ “Patient will receive normal saline or Ringer lactate or other balance salt solution during fluid resuscitation for shock reversal.” NCT02782819 ↗ “Balanced crystalloid solutions (Ringer Lactate, Ringer Acetate, Crystalsol)” NCT03654001 ↗ “Drug : ringer lactate, 0.9% saline, VOLUVEN ®” NCT01972828 ↗ “Only Ringer Lactate administration” NCT02071524 ↗ “Ringer Lactate” NCT01729364 ↗ |
| Known as | Ringer lactate solution | “Colloids (n = 1414; gelatins, dextrans, hydroxyethyl starches, or 4% or 20% of albumin) or crystalloids (n = 1443; isotonic or hypertonic saline or Ringer lactate solution) for...” PMID 24108515 ↗ Nov 2013 |
| Known as | Ringer's Lactate | “This study aimed to compare the effects of 6% hydroxyethyl starch (HES) 130/0.4 and ringer's lactate (RL) priming solution on patients' outcomes undergoing isolated heart valve...” PMID 38105566 ↗ Dec 20231“Ringer's Lactate, solution for infusion will be used as a comparator.” NCT03824457 ↗ |
| Known as | Ringer's lactate solution | “Ringer's lactate solution in a 1:3 ratio” NCT06835023 ↗ |
| Known as | RLS | “Ringer lactate (RLS)” NCT06835023 ↗ |
| Modality | Other / unclassified | “Ringer Lactate® is a balanced solution containing a low chloride concentration” NCT03118362 ↗ |
| Route | Intravenous | “Evidence supporting the choice of intravenous colloid vs crystalloid solutions for management of hypovolemic shock remains unclear.” PMID 24108515 ↗ Nov 2013 |